Patent · US Active

Substituted benzothienopyrimidines

US9296757B2 · kind B2 · utility

0Cited by

4References

9Claims

0Family size

Assignee

Bayer Pharma Aktiengesellschaft · DE

Inventors

Ulrich Klar · Berlin, DE
Georg Kettschau · Berlin, DE
Dirk Kosemund · Berlin, DE
Florian Pühler · Berlin, DE
Knut Eis · Berlin, DE
Philip Lienau · Berlin, DE
Ulf Bömer · Glienicke, DE
Detlev Sülzle · Berlin, DE
Lars Wortmann · Berlin, DE

Key dates

Filing date	May 17, 2013
Grant date	Mar 29, 2016
Priority date	—
Expiry date	May 17, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to substituted benzothienopyrimidine compounds of general formula I: in which R1a, R1b, R2a, R2b, and R2c are as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.